Clerodendrum japonicum Extract Suppresses the Pathogenicity of Rheumatoid Arthritis Fibroblast‐Like Synoviocytes by Inhibiting METTL3‐Mediated ICAM2 mRNA Methylation
Ying Huang, JiangCun Wei, Yan Ma, XiaoPing Mei, MingTao Huang, Liang Lu, JianLong Zhou, ZuJie Qin · 2026
Read Clerodendrum japonicum Extract Suppresses the Pathogenicity of Rheumatoid Arthritis Fibroblast‐Like Synoviocytes by Inhibiting METTL3‐Mediated ICAM2 mRNA Methylation by Ying Huang, JiangCun Wei, Yan Ma, XiaoPing Mei, MingTao Huang, Liang Lu, JianLong Zhou, ZuJie Qin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13591207.txt.
Description
Ying Huang and colleagues tested a traditional plant extract against rheumatoid arthritis cells in 2026. Clerodendrum japonicum has reported anti-inflammatory use, but its action against rheumatoid arthritis was poorly characterised. Overactive joint-lining cells drive lasting inflammation and joint damage in the disease, so those cells were the test target for the extract.
Treatment calmed the harmful behaviour of the activated cells. The effect ran through a pathway where an enzyme adds chemical marks to a messenger molecule, altering its fate. Animal arthritis also eased under treatment. The authors caution that the active ingredient, direct target, body handling, and full safety picture remain unknown, so chemical and drug studies must follow.
Catalog record
| CREATOR | Ying Huang, JiangCun Wei, Yan Ma, XiaoPing Mei, MingTao Huang, Liang Lu, JianLong Zhou, ZuJie Qin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |